Evidence map›Paper›PMID 32471147›Full record

ArticleBiology2020

Metabolomic Reprogramming Detected by

Alessio Metere, Claire E Graves, Mattea Chirico, Maria José Caramujo, Maria Elena Pisanu, Egidio Iorio

Open access · goldAbstract read
In one paragraph

Article in Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer.Endocrinology and metabolism (Seoul, Korea) · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The Influence of Oxidative Stress on Thyroid Diseases.Antioxidants (Basel, Switzerland) · 2021
    Article
  14. Review
  15. Review
  16. Review
  17. The Potential of Metabolomics in the Diagnosis of Thyroid Cancer.International journal of molecular sciences · 2020
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Alessio MetereSurgical Sciences Department, "Sapienza" University of Rome, Viale Regina Elena 261, 00161, Roma, Italy.
Claire E GravesDepartment of Surgery, University of California, San Francisco, 1600 Divisadero St. 4th Floor, San Francisco, CA 94115, USA.
Mattea ChiricoNMR Unit, Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Roma, Italy.
Maria José CaramujoCentre for Ecology, Evolution and Environmental Changes (cE3c), Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.
Maria Elena PisanuNMR Unit, Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Roma, Italy.
Egidio IorioNMR Unit, Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Roma, Italy.
Istituto Superiore di Sanità · ITSapienza University of Rome · ITUniversity of California, San Francisco · USUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid cancer cells demonstrate an increase in oxidative stress and decreased antioxidant action, but the effects of this increased oxidative stress on cell function remain unknown. We aimed to identify changes in the metabolism of thyroid cancer cells caused by oxidative stress, using proton nuclear magnetic resonance (

Indexed as

metabolomic analysesNMRoxidative stressthyroid cancer

Identifiers

PMID32471147
PMCPMC7345942
OpenAlexW3029488353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.